We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

donderdag 4 januari 2018

Bone Marrow Transplantation - Table of Contents alert Volume 53 Issue n1

If you are unable to see the message below, click here to view.
Bone Marrow Transplantation
TABLE OF CONTENTS

Volume 53, Issue 1 (January 2018)

In this issue
Editorial
Reviews
Special Report
Original Articles
Letters to the Editor

Also new
AOP
 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Editorial

Top

Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation

N Kröger, M Bishop, S Giralt and A Wayne

Bone Marrow Transplant 2018 53: 1-2; advance online publication, October 9, 2017; 10.1038/bmt.2017.218

Full Text

Reviews

Top

Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?

A Hegde and H S Murthy

Bone Marrow Transplant 2018 53: 3-10; advance online publication, October 30, 2017; 10.1038/bmt.2017.192

Abstract | Full Text

Post-autologous transplant maintenance therapies in lymphoma: current state and future directions

P A Riedell and M R Bishop

Bone Marrow Transplant 2018 53: 11-21; advance online publication, October 2, 2017; 10.1038/bmt.2017.196

Abstract | Full Text

Special Report

Top

Is there any role for physical therapy in chronic GvHD?

J Mohammed, B N Savani, A El-Jawahri, J Vanderklish, A L Cheville and S K Hashmi

Bone Marrow Transplant 2018 53: 22-28; advance online publication, August 7, 2017; 10.1038/bmt.2017.155

Abstract | Full Text

Original Articles

Top

LYMPHOMA

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma

E Joffe, D Rosenberg, U Rozovski, C Perry, I Kirgner, S Trestman, O Gur, F Aviv, N Sarid, A Kolomansky, L Gepstein, Y Herishanu and E Naparstek

Bone Marrow Transplant 2018 53: 29-33; advance online publication, October 16, 2017; 10.1038/bmt.2017.205

Abstract | Full Text

PLASMA CELL DISORDERS

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma

D Sivaraj, W Bacon, G D Long, D A Rizzieri, M E Horwitz, K M Sullivan, Y Kang, Z Li, N J Chao and C Gasparetto

Bone Marrow Transplant 2018 53: 34-38; advance online publication, October 30, 2017; 10.1038/bmt.2017.208

Abstract | Full Text

INHERITED AND GENETIC DISORDERS

Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major

S Santarone, A Pepe, A Meloni, A Natale, L Pistoia, P Olioso, G Papalinetti, L Cuccia, A Spasiano, R Lisi, M Di Ianni, T Bonfini, P Accorsi, S Salvadori, F Papola, S Angelini and P Di Bartolomeo

Bone Marrow Transplant 2018 53: 39-43; advance online publication, October 9, 2017; 10.1038/bmt.2017.214

Abstract | Full Text

CONDITIONING

Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation

K Yoshimura, I Yano, T Yamamoto, M Kawanishi, Y Isomoto, A Yonezawa, T Kondo, A Takaori-Kondo and K Matsubara

Bone Marrow Transplant 2018 53: 44-51; advance online publication, October 9, 2017; 10.1038/bmt.2017.213

Abstract | Full Text

SUPPORTIVE CARE

Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation

F Farowski, V Bücker, J J Vehreschild, L Biehl, R Cruz-Aguilar, C Scheid, U Holtick, N Jazmati, H Wisplinghoff, O A Cornely and M J G T Vehreschild

Bone Marrow Transplant 2018 53: 52-57; advance online publication, November 13, 2017; 10.1038/bmt.2017.203

Abstract | Full Text

GRAFT-VERSUS-HOST DISEASE

‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)

L Giaccone, G Mancini, N Mordini, G Gargiulo, V De Cecco, S Angelini, M Arpinati, D Baronciani, V Bozzoli, S Bramanti, E Calore, I M Cavattoni, M Cimminiello, A A Colombo, L Facchini, S Falcioni, M Faraci, R Fedele, S Guidi, A P Iori, S Marotta, M C Micò, G Milone, F Onida, D Pastore, F Patriarca, M Pini, R Raimondi, A Rovelli, S Santarone, A Severino, C Skert, M T L Stanghellini, C Tecchio, E Vassallo, M Chiarucci, B Bruno, F Bonifazi and A Olivieri

Bone Marrow Transplant 2018 53: 58-63; advance online publication, October 30, 2017; 10.1038/bmt.2017.223

Abstract | Full Text

Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402

L M Turcotte, T E DeFor, L F Newell, C S Cutler, M R Verneris, J Wu, A Howard, M L MacMillan, J H Antin, G M Vercellotti, Ane Slungaard, B R Blazar, D J Weisdorf, A Panoskaltsis-Mortari and S G Holtan

Bone Marrow Transplant 2018 53: 64-68; advance online publication, October 23, 2017; 10.1038/bmt.2017.236

Abstract | Full Text

IMMUNE RECOVERY

Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients

A Gaballa, A Norberg, A Stikvoort, J Mattsson, B Sundberg, M Uzunel, M Remberger and M Uhlin

Bone Marrow Transplant 2018 53: 69-77; advance online publication, October 9, 2017; 10.1038/bmt.2017.216

Abstract | Full Text

INFECTIONS

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study

D Shanis, P Anandi, C Grant, A Bachi, N Vyas, M A Merideth, P A Pophali, E Koklanaris, S Ito, B N Savani, A J Barrett, M Battiwalla and P Stratton

Bone Marrow Transplant 2018 53: 78-83; advance online publication, October 16, 2017; 10.1038/bmt.2017.210

Abstract | Full Text

QOL AND PATIENTS' CARE

Treatment intensity and symptom burden in hospitalized adolescent and young adult hematopoietic cell transplant recipients at the end of life

J M Snaman, A C Talleur, J Lu, D R Levine, E C Kaye, A Sykes, Z Lu, B M Triplett and J N Baker

Bone Marrow Transplant 2018 53: 84-90; advance online publication, November 13, 2017; 10.1038/bmt.2017.187

Abstract | Full Text

Letters to the Editor

Top

Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation

P Galieni, E Troiani, C Bigazzi, S Mazzotta, M Ruggieri, V Pezzoni, A Dalsass, F Mestichelli, P Caraffa, F Travaglini, S Ferretti, M Angelini, S Angelini and S Falcioni

Bone Marrow Transplant 2018 53: 91-93; advance online publication, October 2, 2017; 10.1038/bmt.2017.206

Full Text

Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome

V Wais, L Kündgen, S R Bohl, S von Harsdorf, R F Schlenk, K Döhner, V Teleanu, L Bullinger, T M Nguyen, K Drognitz, J-C Moulin, M Binnenhei, M Bentz, H Döhner, D Bunjes, F Kuchenbauer and M Ringhoffer

Bone Marrow Transplant 2018 53: 94-96; advance online publication, November 13, 2017; 10.1038/bmt.2017.211

Full Text

Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation

C Ustun, C Brunstein, T DeFor, A Rashidi, S Yohe, N Bejanyan, S Cooley, E Warlick, J Miller, M A Linden and D Weisdorf

Bone Marrow Transplant 2018 53: 97-100; advance online publication, October 9, 2017; 10.1038/bmt.2017.212

Full Text

Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome

P G Hemmati, K Pfeifer, L G Vuong, C F Jehn, T H Terwey, P le Coutre, B Dörken and R Arnold

Bone Marrow Transplant 2018 53: 101-103; advance online publication, October 9, 2017; 10.1038/bmt.2017.215

Full Text

Engender trust and edify

A D'Souza, R Spellecy and A Derse

Bone Marrow Transplant 2018 53: 104; advance online publication, October 16, 2017; 10.1038/bmt.2017.217

Full Text

Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis

S Pagliuca, A M Risitano, F S De Fontbrune, M Robin, A P Iori, S Marotta, D Michonneau, A Villate, D Desmier, G Socié and R P De Latour

Bone Marrow Transplant 2018 53: 105-107; advance online publication, November 13, 2017; 10.1038/bmt.2017.220

Full Text

Correlation between pediatric donor characteristics and cell compositions in mixture allografts of combined G-CSF-mobilized PBSCs and bone marrow allografts

L-Q Cao, L Liu, L-P Xu, X-H Zhang, Y Wang, Q-Z Fan, Y-R Liu, K-Y Liu, X-J Huang and Y-J Chang

Bone Marrow Transplant 2018 53: 108-110; advance online publication, October 23, 2017; 10.1038/bmt.2017.224

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature